Biosciences, Biopharmaceutical and Biotechnology Companies in Denmark.

7TM Pharma:Hørsholm, Denmark: leverages its core competencies within structure-based drug discovery on 7TM (GPCR) receptor targets (Site Directed Drug Discovery®) and early development to create a versatile pipeline of novel drugs for large therapeutic markets.  The core therapeutic focus is metabolic disorders. The lead compound, targeting obesity, is on its way to Phase IIa clinical studies and a further obesity compound will enter Phase I/II studies this year. Inflammatory disorders is the secondary therapeutic interest, the lead program there targeting allergic rhinitis and asthma. Furthermore, 7TM engages in discovery work on other 7TM receptor targets based on synergies with ongoing projects, therapeutic potential in other disease areas, target validation combined with the ability to apply chemistry, and high interest of potential collaboration partners.

ACADIA Pharmaceuticals, Malmö: A biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. We currently have five drug programs in clinical and preclinical development directed at large unmet medical needs and major commercial markets.

Agroferm A/S, Limfjordsvej 4, 6715 Esbjerg N :Long-standing development cooperation between a number of companies and the University of Southern Denmark in Esbjerg led in 2002 to the decision on establishing a new and high technological amino acid production in Esbjerg. The production is based on our own developed patent and the state-of-art knowledge within biotechnology, fermentations and process technology.  

ALK-Abelló, Hørsholm: The world-leading producer of  pharmaceuticals for specific allergy vaccination. Not only do our allergy vaccines treat the allergic symptoms, but also the underlying causes of allergy – and at the same time they prevent asthma.

Alpharma Inc. Copenhagen:A global specialty pharmaceutical company with leadership positions in products for humans and animals. Uniquely positioned to expand internationally, Alpharma is presently active in more than 60 countries. :

Bavarian Nordic A/S, Kvistgaard: A leading international biopharmaceutical company developing, products and marketing innovative vaccines to prevent and treat infectious diseases and cancer. With operations in Denmark, Germany, the USA, and Singapore, Bavarian Nordic employs over 220 people and is listed on the Copenhagen Stock Exchange under the trading symbol BAVA.

Biogen Idec, Hillerød: A global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, is committed to transforming scientific discovery into advances in healthcare. The company's core capabilities include drug discovery, research, development, biomanufacturing, and a global commercial infrastructure. 

Bioneer A/S, Hørsholm:manages a diverse portfolio of technologies. In each of these Bioneer dedicates the necessary resources to transform discovery into market ready offerings. Bioneer focuses on IP generation and licensing to generate revenues, but also maintains a high quality service offering to help with discovery and development of biotechnology products.